Insob Hwang

ORCID: 0000-0003-4015-164X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Drug-Induced Adverse Reactions
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • COVID-19 diagnosis using AI
  • Viral gastroenteritis research and epidemiology
  • Food Allergy and Anaphylaxis Research
  • Bacillus and Francisella bacterial research
  • Pharmacovigilance and Adverse Drug Reactions
  • Health and Wellbeing Research
  • COVID-19 Clinical Research Studies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Health Promotion and Cardiovascular Prevention
  • Traditional Chinese Medicine Studies
  • Allergic Rhinitis and Sensitization

Korea Disease Control and Prevention Agency
2017-2022

Korea Center for Disease Control and Prevention
2017-2022

This study aimed to disseminate information on coronavirus disease 2019 (COVID-19) vaccine safety among adolescents aged 12 17 years in the Republic of Korea.Two databases were used assess COVID-19 who completed primary Pfizer-BioNTech vaccination series. Adverse events reported web-based management system (CVMS) and collected text message-based analyzed.From March 5, 2021 February 13, 2022, 12,216 adverse 12- 17-yearolds CVMS, which 97.1% non-serious 2.9% serious events, including 85...

10.24171/j.phrp.2022.0122 article EN cc-by-nc-nd Osong Public Health and Research Perspectives 2022-06-10

This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 October 31, 2021, and determine whether any significant patterns emerged an analysis the characteristics suspected event cases for each type vaccine.Adverse COVID-19 by medical doctors forensic pathologists were analyzed. Cases anaphylaxis classified using Brighton Collaboration definition.By a total 353,535 (0.45%) after 78,416,802...

10.24171/j.phrp.2021.0310 article EN cc-by-nc-nd Osong Public Health and Research Perspectives 2021-12-21

The South Korea mass vaccination programme administered 3.8 million doses of COVID-19 vaccinations between 26 February and 30 April 2021. After 173 suspected anaphylaxis reports to the nationwide monitoring system for adverse events following immunisation, 44 cases were confirmed using Brighton Collaboration case definitions. rates per 18.2 6.2 Vaxzevria Comirnaty, respectively. Median time onset was 14 min after most had recovered at review.

10.2807/1560-7917.es.2021.26.33.2100694 article EN cc-by Eurosurveillance 2021-08-19

Objectives: On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of Advisory Committee Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and Pfizer-BioNTech) in Korea. This report provides a summary adverse events following as April 30, 2021.Methods: Adverse immunization are notifiable by medical doctors to Korea Management System (KIMS) under national surveillance system. We analyzed all...

10.24171/j.phrp.2021.0157 article EN cc-by-nc-nd Osong Public Health and Research Perspectives 2021-08-13

OBJECTIVES: We aimed to evaluate the severity of suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection according variants concern in Gyeongsangbuk-do and Daegu, Korea.METHODS: The database disease 2019 (COVID-19) cases reported from epidemiological investigations through integrated system operated by Korea Disease Control Prevention Agency, January 20, 2020 May 7, 2022 was combined with data Health Insurance Review Assessment Service system. odds ratio (SOR)...

10.4178/epih.e2023007 article EN cc-by Epidemiology and Health 2022-12-21

In Korea, a national coronavirus disease 2019 (COVID-19) vaccination program was implemented, including 4 vaccines against COVID-19. A text messaging-based survey, in addition to passive adverse event reporting system, launched quickly report unusual symptoms post-vaccination. This study compared the frequency of events after COVID-19 based on vaccine type and 2-dose regimen (homologous or heterologous).Self-reported were collected through text-message survey for 7 days each vaccination....

10.4178/epih.e2023006 article EN cc-by Epidemiology and Health 2022-12-26

Health risk appraisal (HRA) is a systematic approach for collecting information regarding individual factors, predicting the probability of disease occurrence and death, linking patients with interventions to promote health prevent disease. Because factors cardiovascular are well established, several prediction models have been developed over multiple decades. The model Korean national screening program will be revised updated using latest well-validated studies reflect current...

10.5124/jkma.2017.60.9.746 article EN cc-by-nc Journal of Korean Medical Association 2017-01-01
Coming Soon ...